Evidence for this is provided by observations found in breast cancer that a high expression of FPN and low expression of hepcidin predicts a favorable prognosis, while a low expression of FPN is related to metastatic progression and reduced survival [169,170,171]. This evidence concerns the gene SLC40A1 and breast cancer.